NasdaqCM - Delayed Quote USD
Context Therapeutics Inc. (CNTX)
1.0000
+0.0563
+(5.97%)
At close: 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-14,556.4340
-14,556.4340
-21,047.6180
-13,549.2340
-8,799.4870
Investing Cash Flow
-14,757.3160
-14,757.3160
--
-536.8360
-250
Financing Cash Flow
109,293.7470
109,293.7470
--
-102.0710
58,394.0360
End Cash Position
94,429.8240
94,429.8240
14,449.8270
35,497.4450
49,685.5860
Capital Expenditure
-14,757.3160
-14,757.3160
--
-536.8360
-250
Issuance of Capital Stock
109,293.7470
109,293.7470
--
--
58,394.0360
Free Cash Flow
-29,313.7500
-29,313.7500
-21,047.6180
-14,086.0700
-9,049.4870
12/31/2021 - 10/20/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BTTX Better Therapeutics, Inc.
0.0002
0.00%
LIXT Lixte Biotechnology Holdings, Inc.
1.2560
-3.99%
UNCY Unicycive Therapeutics, Inc.
0.6400
+0.91%
COYA Coya Therapeutics, Inc.
6.53
-0.46%
NLSP NLS Pharmaceutics AG
1.5000
+1.35%
AFMD Affimed N.V.
0.8900
+15.54%
ABVC ABVC BioPharma, Inc.
0.9198
+5.00%
ELEV Elevation Oncology, Inc.
0.3720
-1.80%
MRSN Mersana Therapeutics, Inc.
0.3623
-7.10%
ENVB Enveric Biosciences, Inc.
1.3348
+3.47%